Life science firm value is managed through strategic information release.

Evidence

As this quote shows, value cannot be reduced to the biological, lively, embodied, or material qualities of commodities. Rather, and as another informant noted, the lack of trading information (e.g., earnings from product or services sales) means that life science firms are dependent on ”managing sentiment” through the strategic release of other information (e.g., patenting activity, partnership activity, licensing activity, etc.) — Kean Birch, Rethinking Value in the Bio-economy, 102

Categorization

• DEFINE: Defines ‘financial materiality’ and ‘managing sentiment’ as core practices in how value is constructed for assetized firms lacking trading earnings.
• SEED: Article angle: how ‘managing sentiment’ as a valuation practice parallels brand/PR performance in attention economies more broadly.
• XREF: connects to: A corporate research group that openly publishes can elevate both science and company reputation. — Toole, Floyd E, Sound reproduction- the acoustics and…, 199

Related

• In the bioeconomy, informational signaling about assets, not product sales, constitutes firm value. (similarity 0.83)
• Value is constituted by knowledge and practice, not merely hype. (similarity 0.78)
• A corporate research group that openly publishes can elevate both science and company reputation. (similarity 0.78)

Broader Connections

• A corporate research group that openly publishes can elevate both science and company reputation. #exemplifies (0.85) — Toole, Floyd E, Sound reproduction- the acoustics and…, 199